Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin PK/PD in Chinese Patients with MRSA Infection
NCT02443064Phase 4Unknown
- Sponsor
- Zhejiang University
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in septicemia, endocarditis (IE), Staphylococcus aureus infection, sponsored by Zhejiang University. Status: unknown.
02
Drugs
vancomycin
03
Conditions
septicemiaendocarditis (IE)Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT02443064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443064.